mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
0.0005 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.002 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.004 |